[{"Assets_0_Q2_USD":465391000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":22590000.0,"NetIncomeLossConverted_1_Q2_USD":-12336000.0,"NetIncomeLossConverted_2_Q2_USD":-19347000.0,"StockholdersEquity_0_Q2_USD":191344000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":11935000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":11967000.0,"EarningsPerShareBasic_1_Q2_USD":-1.03,"EarningsPerShareBasic_2_Q2_USD":-1.62,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":11967000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":11935000.0,"EarningsPerShareDiluted_1_Q2_USD":-1.03,"EarningsPerShareDiluted_2_Q2_USD":-1.62,"RevenuesConverted_2_Q2_USD":98244000.0,"RevenuesConverted_1_Q2_USD":48470000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]